Monitoring of occupational exposure to polycyclic aromatic hydrocarbons in a carbon-electrode manufacturing plant

被引:19
作者
Van Delft, JHM
Steenwinkel, MJST
Van Asten, JG
Van Es, J
Kraak, A
Baan, RA
机构
[1] TNO, Nutr & Food Res Inst, Div Toxicol, Dept Mol Toxicol, NL-3700 AJ Zeist, Netherlands
[2] Aluminium & Chemie Rotterdam BV, NL-3197 KJ Botlek Rotterdam, Netherlands
[3] ArboNed Utrecht, NL-3500 GK Utrecht, Netherlands
关键词
biological monitoring; polycyclic aromatic hydrocarbon; DNA adducts; 1-hydroxypyrene;
D O I
10.1016/S0003-4878(97)00055-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
An investigation is presented of occupational exposure to polycyclic aromatic hydrocarbons (PAH) in a carbon-electrode manufacturing plant, as assessed by three monitoring methods, viz. environmental monitoring of the external dose by analysis of personal air samples, biological monitoring of the internal dose by analysis of urinary 1-hydroxypyrene (1-OHpyrene), and biological effect monitoring by dosimetry of PAH-DNA adducts in blood lymphocytes. On the basis of job conditions, workers at the plant were divided into three groups with presumed lon, intermediate and high exposure to air-borne PAH, respectively. All air samples showed levels of total PAH below the current RUG-value in the Netherlands, which is 200 mu g/m(3), whereas the benzo[a]pyrene level was occasionally higher than the recommended concentration of 2 mu g/m(3). The values of 1-OHpyrene in urine from the intermediate and high exposure groups were significantly higher than those of the low exposure group, namely 3.6- and 8.2-fold, respectively. Clear external and internal exposure was thus demonstrated for workers of the high and intermediate exposure groups, but this did not result in a measurable effect at the DNA level in blood lymphocytes, Tobacco smoking, on the other hand, caused a significant increase of the levels of PAH-DNA adducts but did not affect l-OHpJrene values. These data suggest that smoking is a more important risk factor for adverse health effects, i.e. cancer, than occupational exposure to PAH in this plant. (C) 1998 British Occupational Hygiene Society. Published by Elsevier Science Ltd.
引用
收藏
页码:105 / 114
页数:10
相关论文
共 36 条
  • [1] TABULATION AND ASSESSMENT OF 113 HUMAN SURVEILLANCE CYTOGENETIC STUDIES CONDUCTED BETWEEN 1965 AND 1984
    ASHBY, J
    RICHARDSON, CR
    [J]. MUTATION RESEARCH, 1985, 154 (02): : 111 - 133
  • [2] The use of benzo[a]pyrene diolepoxide-modified DNA standards for adduct quantification in P-32-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study
    Baan, RA
    Steenwinkel, MJST
    vanAsten, S
    Roggeband, R
    vanDelft, JHM
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 378 (1-2) : 41 - 50
  • [3] HUMAN BIOMONITORING AND THE P-32 POSTLABELING ASSAY
    BEACH, AC
    GUPTA, RC
    [J]. CARCINOGENESIS, 1992, 13 (07) : 1053 - 1074
  • [4] COMPARATIVE-STUDIES BY COMET TEST AND SCE ANALYSIS IN HUMAN-LYMPHOCYTES FROM 200 HEALTHY-SUBJECTS
    BETTI, C
    DAVINI, T
    GIANNESSI, L
    LOPRIENO, N
    BARALE, R
    [J]. MUTATION RESEARCH-GENETIC TOXICOLOGY, 1995, 343 (04): : 201 - 207
  • [5] BUCHET JP, 1992, BRIT J IND MED, V49, P761
  • [6] CARANO AV, 1988, MUTAT RES, V204, P379
  • [7] ADDUCTS TO MACROMOLECULES IN THE BIOLOGICAL MONITORING OF WORKERS EXPOSED TO POLYCYCLIC AROMATIC-HYDROCARBONS
    DELLOMO, M
    LAUWERYS, RR
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 1993, 23 (02) : 111 - 126
  • [8] RISK ASSESSMENT OF CARCINOGENIC CHEMICALS IN THE NETHERLANDS
    DENENGELSE, L
    DEHOLLANDER, AEM
    DREEFVANDERMEULEN, HC
    FERON, VJ
    MOHN, GR
    MULDER, GJ
    NOORDAM, PC
    ROELFZEMA, H
    SWAEN, GMH
    VERBEEK, ALM
    VERSCHUUREN, HG
    VOGEL, EW
    VANZORGE, JA
    VANVLIET, PW
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1994, 19 (01) : 14 - 30
  • [9] MORTALITY IN RELATION TO SMOKING - 40 YEARS OBSERVATIONS ON MALE BRITISH DOCTORS
    DOLL, R
    PETO, R
    WHEATLEY, K
    GRAY, R
    SUTHERLAND, I
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6959) : 901 - 911
  • [10] FENNELL TT, 1996, REGEL TOXICOL PHARM, V24, P9